相关实验视频
Updated: Sep 19, 2025

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
504
针对循环瘤细胞 - 中性粒细胞相互作用:用于抑制癌症转移的纳米工程策略
Yong Su1, Mingjing Leng1, Qingqing Yang1
1School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, People's Republic of China.
Journal of nanobiotechnology
|June 17, 2025
概括
针对循环瘤细胞 (CTC) 和中性粒细胞之间的相互作用可以抑制癌症转移. 纳米技术提供了一种有希望的方法来破坏这种交叉通话,提高治疗效率并减少转移性癌症患者的副作用.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 转移是癌症死亡的主要原因,转移性疾病患者的治疗选择有限.
- 循环瘤细胞 (CTC) 通过进入血流并与白细胞,特别是中性粒细胞形成,从而传播癌症.
- 这些CTC-中性粒细胞相互作用促进癌细胞的生存,入侵和前转移性环境的创造.
研究的目的:
- 审查纳米工程策略来破坏CTC-中性粒细胞相互作用.
- 探索纳米技术在抗转移疗法中的潜力.
- 确定针对转移的纳米治疗药物的局限性和未来方向.
主要方法:
- 对基于纳米技术的药物输送系统的现有文献进行系统审查.
- 分析了CTC与中性粒细胞交叉通话的机制.
- 评估针对这些相互作用的纳米工程策略.
主要成果:
- CTC-中性细胞相互作用增强癌细胞的生存,增殖,入侵和转移.
- 与传统疗法相比,基于纳米技术的系统显示出有针对性交付和减少副作用的潜力.
- 破坏CTC-中性粒细胞交叉是抑制转移性传播的可行策略.
结论:
- 对CTC-中性粒细胞交叉的药理学破坏是一个有前途的抗转移策略.
- 纳米工程药物输送系统为针对这种交叉通话提供了优势.
- 需要进一步开发临床可转化纳米疗法,以有效打击转移性癌症.
更多相关视频
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
8.7K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.1K
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K